Subscribe to Newsletter

Small Molecules

Business & Regulation Standards & Regulation

Showdown Over the Abortion Pill in the US

| Stephanie Vine | 4 min read

The Supreme Court will decide the fate of the abortion pill mifepristone in the US on March 26, 2024.

Business & Regulation Profession

The Start of a Journey

| Stephanie Vine | 6 min read

Meet Brad Hocking – a final year PhD student at Imperial College London who is passionate about small molecule drug discovery.

Discovery & Development Small Molecules

System Addict

| 4 min read

Researchers have developed a new chemical entity that can cut alcohol consumption in half

Discovery & Development Drug Discovery

Addressing Epilepsy

| Stefanie Dedeurwaerdere | 4 min read

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Business & Regulation Business Practice

Active Manufacturing Responsibility and the Other AMR

| Marijn Verhoef, Martijn van Gerven | 5 min read

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Business & Regulation Standards & Regulation

Chemistry and Humility

| Rob Coker | 3 min read

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Discovery & Development Ingredients

Manufacturers Urged to Take Steps to Avoid DEG and EG Contamination

| Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Discovery & Development Drug Discovery

SMM Screening

| 5 min read

Why small molecule microarrays are leading the way in small molecule drug discovery

Discovery & Development Drug Discovery

Nobel Prize for mRNA COVID-19 Vaccine Technology

| Stephanie Vine | 7 min read

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Discovery & Development Drug Discovery

Addressing Alzheimer’s

| 3 min read

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register